Efficacy of combination chemotherapy using irinotecan and nedaplatin for patients with recurrent and refractory endometrial carcinomas: preliminary analysis and literature review-Reference-Cited by-同舟云学术

Efficacy of combination chemotherapy using irinotecan and nedaplatin for patients with recurrent and refractory endometrial carcinomas: preliminary analysis and literature review

Published:2017-11-09 Issue:1 Volume:81 Page:111-117
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Miyamoto Morikazu^ORCID,Takano Masashi^ORCID,Kuwahara Mika^ORCID,Soyama Hiroaki^ORCID,Kato Kento^ORCID,Matuura Hiroko^ORCID,Sakamoto Takahiro^ORCID,Takasaki Kazuki^ORCID,Aoyama Tadashi^ORCID,Yoshikawa Tomoyuki^ORCID,Furuya Kenichi^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/article/10.1007/s00280-017-3454-y/fulltext.html

Reference38 articles.

1. Matsuda T, Marugame T, Kamo KI, Katanoda K, Ajiki W, Sobue T, The Japan Cancer Surveillance Research Group (2011) Cancer incidence and incidence rates in Japan in 2005: based on data from 12 population-based cancer registries in the monitoring of cancer incidence in Japan (MCIJ) project. Jpn J Clin Oncol 41:139–147. doi: 10.1093/jjco/hyq169

2. Nagase S, Katabuchi H, Hiura M, Sakuragi N, Aoki Y, Kigawa J, Saito T, Hachisuga T, Ito K, Uno T, Katsumata N, Komiyama S, Susumu N, Emoto M, Kobayashi H, Metoki H, Konishi I, Ochiai K, Mikami M, Sugiyama T, Mukai M, Sagae S, Hoshiai H, Aoki D, Ohmichi M, Yoshikawa H, Iwasaka T, Udagawa Y, Yaegashi N, Japan Society of Gynecologic Oncology (2010) Evidence-based guidelines for treatment of uterine body neoplasm in Japan: Japan Society of Gynecologic Oncology (JSGO) 2009 edition. Int J Clin Oncol 15:531–542. doi: 10.1007/s10147-010-0138-6

3. Susumu N, Sagae S, Udagawa Y, Niwa K, Kuramoto H, Satoh S, Kudo R (2008) Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: a Japanese Gynecologic Oncology Group study. Gynecol Oncol 108:226–233. doi: 10.1016/j.ygyno.2007.09.029

4. Randall ME, Filiaci VL, Muss H, Spirtos NM, Mannel RS, Fowler J, Thigpen JT, Benda JA (2006) Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group study. J Clin Oncol 24:36–44. doi: 10.1200/JCO.2004.00.7617

5. Markman M, Rothman R, Hakes T, Reichman B, Hoskins W, Rubin S, Jones W, Almadrones L, Lewis JL Jr (1991) Second-line platinum therapy in patients with ovarian cancer previously treated with cisplatin. J Clin Oncol 9:389–93. doi: 10.1200/JCO.1991.9.3.389

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Somatic Mutation Landscape of UDP-Glycosyltransferase (UGT) Genes in Human Cancers;Cancers;2022-11-21

2. Application of Approved Cisplatin Derivatives in Combination Therapy against Different Cancer Diseases;Molecules;2022-04-11

3. A Marine Terpenoid, Heteronemin, Induces Both the Apoptosis and Ferroptosis of Hepatocellular Carcinoma Cells and Involves the ROS and MAPK Pathways;Oxidative Medicine and Cellular Longevity;2021-01-04

4. Seven New Cytotoxic and Antimicrobial Xanthoquinodins from Jugulospora vestita;Journal of Fungi;2020-09-25

5. Facile entry to germanate and stannate complexes [(η6-arene)RuCl(η2-dppm)]+[ECl3]- (E = Ge, Sn) as potent anti-cancer agents;Journal of Organometallic Chemistry;2020-06